10 Best Human Capital Management Software for February 2026
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The human capital management (HCM) software sector has faced headwinds amid broader market corrections, with many stocks posting negative 1-year returns ranging from -1.8% to -41.2%. Despite this, ValueSense analysis highlights several companies trading below their calculated intrinsic values, presenting potential opportunities for value-oriented investors. These picks were selected using ValueSense's proprietary methodology, focusing on intrinsic value comparisons, quality ratings, ROIC, revenue growth, FCF margins, and debt levels. Stocks were drawn from curated watchlists emphasizing HCM themes, prioritizing those with strong gross margins (often above 70%) and positive free cash flow generation, even in a challenging environment. This educational analysis frames HCM stocks as part of diversified watchlists for retail investors exploring undervalued tech and healthcare plays.
Featured Stock Analysis
Stock #1: SAP SE (SAP)
| Metric | Value |
|---|---|
| Market Cap | $236.7B |
| Quality Rating | 6.6 |
| Intrinsic Value | $269.6 |
| 1Y Return | -28.0% |
| Revenue | €35.3B |
| Free Cash Flow | €8,395.8M |
| Revenue Growth | 3.4% |
| FCF margin | 23.8% |
| Gross margin | 73.5% |
| ROIC | 17.2% |
| Total Debt to Equity | 17.8% |
Investment Thesis
SAP SE, a global leader in enterprise software including HCM solutions, shows a ValueSense quality rating of 6.6 and an intrinsic value of $269.6, suggesting significant undervaluation relative to its current market position in a $236.7B market cap giant. With revenue of €35.3B, free cash flow at €8,395.8M (23.8% FCF margin), and a solid 73.5% gross margin, SAP demonstrates resilient profitability despite modest 3.4% revenue growth and a -28.0% 1Y return. Its ROIC of 17.2% and low total debt to equity of 17.8% underscore efficient capital allocation in the HCM space, positioning it as a stable core holding for long-term analysis.
This analysis highlights SAP's scale advantages in HCM software, where high margins support ongoing innovation amid market volatility.
Key Catalysts
- Strong FCF generation €8,395.8M enabling R&D and acquisitions in HCM tech
- High gross margin 73.5% indicating pricing power in enterprise software
- Healthy ROIC 17.2% reflecting efficient use of invested capital
- Low debt levels (17.8% total debt to equity) for financial flexibility
Risk Factors
- Modest revenue growth 3.4% in a competitive HCM market
- Negative 1Y return -28.0% tied to broader tech sector pressures
- Currency fluctuations impacting euro-denominated revenue
Stock #2: Workday, Inc. (WDAY)
| Metric | Value |
|---|---|
| Market Cap | $46.5B |
| Quality Rating | 10.0 |
| Intrinsic Value | $217.7 |
| 1Y Return | -32.5% |
| Revenue | $9,216.0M |
| Free Cash Flow | $2,585.0M |
| Revenue Growth | 0.3% |
| FCF margin | 28.0% |
| Gross margin | 77.5% |
| ROIC | 8.1% |
| Total Debt to Equity | 42.7% |
Investment Thesis
Workday, Inc. stands out with a top-tier ValueSense quality rating of 10.0 and intrinsic value of $217.7 for its $46.5B market cap, despite a -32.5% 1Y return. Revenue reached $9,216.0M with $2,585.0M in free cash flow (28.0% FCF margin) and an impressive 77.5% gross margin, though revenue growth was tepid at 0.3%. ROIC of 8.1% and total debt to equity of 42.7% indicate a high-quality HCM cloud platform with room for margin expansion as growth stabilizes.
Workday's focus on HCM and finance software positions it for recovery, with metrics suggesting undervaluation in enterprise SaaS.
Key Catalysts
- Exceptional quality rating 10.0 signaling superior business moat
- Robust FCF margin 28.0% and gross margin 77.5% for reinvestment
- Scalable cloud HCM model driving potential revenue acceleration
- Strong market cap $46.5B with growth tailwinds in enterprise adoption
Risk Factors
- Low revenue growth 0.3% amid economic slowdowns
- Elevated 1Y decline -32.5% reflecting SaaS valuation resets
- Higher debt to equity 42.7% increasing sensitivity to rates
Stock #3: Paychex, Inc. (PAYX)
| Metric | Value |
|---|---|
| Market Cap | $36.5B |
| Quality Rating | 6.7 |
| Intrinsic Value | $55.3 |
| 1Y Return | -29.9% |
| Revenue | $6,033.9M |
| Free Cash Flow | $2,057.5M |
| Revenue Growth | 12.4% |
| FCF margin | 34.1% |
| Gross margin | 73.4% |
| ROIC | 19.6% |
| Total Debt to Equity | 2.2% |
Investment Thesis
Paychex, Inc. offers a quality rating of 6.7 and intrinsic value of $55.3 in its $36.5B market cap payroll and HCM provider role. Key metrics include $6,033.9M revenue, $2,057.5M free cash flow (34.1% FCF margin), 12.4% revenue growth, and 73.4% gross margin, despite a -29.9% 1Y return. Exceptional ROIC 19.6% and minimal total debt to equity 2.2% highlight its conservative, cash-generative profile.
This makes Paychex a defensive HCM pick with strong fundamentals for steady analysis.
Key Catalysts
- High revenue growth 12.4% in payroll HCM services
- Leading FCF margin 34.1% supporting dividends and buybacks
- Top ROIC 19.6% and low debt 2.2% for stability
- Consistent gross margin 73.4% amid small business demand
Risk Factors
- Sharp 1Y return drop -29.9% from market rotations
- Dependence on U.S. SMB hiring cycles
- Competition in outsourced HCM space
Stock #4: Humana Inc. (HUM)
| Metric | Value |
|---|---|
| Market Cap | $23.5B |
| Quality Rating | 5.3 |
| Intrinsic Value | $735.1 |
| 1Y Return | -34.3% |
| Revenue | $126.4B |
| Free Cash Flow | $1,547.0M |
| Revenue Growth | 9.9% |
| FCF margin | 1.2% |
| Gross margin | 23.1% |
| ROIC | 19.9% |
| Total Debt to Equity | 67.8% |
Investment Thesis
Humana Inc., blending healthcare with HCM elements, has a quality rating of 5.3 and striking intrinsic value of $735.1 against its $23.5B market cap. It generated $126.4B revenue, $1,547.0M free cash flow (1.2% FCF margin), 9.9% growth, and 23.1% gross margin, with ROIC at 19.9% despite -34.3% 1Y return and 67.8% debt to equity.
Humana's scale in health services offers undervaluation potential per ValueSense metrics.
Key Catalysts
- Massive revenue scale $126.4B with 9.9% growth
- High ROIC 19.9% indicating capital efficiency
- Healthcare HCM synergies in benefits management
- Intrinsic value upside $735.1
Risk Factors
- Low FCF margin 1.2% pressuring cash flows
- High debt 67.8% amid regulatory risks
- Steep 1Y decline -34.3%
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Stock #5: Dayforce Inc (DAY)
| Metric | Value |
|---|---|
| Market Cap | $11.1B |
| Quality Rating | 5.5 |
| Intrinsic Value | $67.5 |
| 1Y Return | -1.8% |
| Revenue | $1,893.3M |
| Free Cash Flow | $192.0M |
| Revenue Growth | 11.7% |
| FCF margin | 10.1% |
| Gross margin | 52.9% |
| ROIC | 2.6% |
| Total Debt to Equity | 22.1% |
Investment Thesis
Dayforce Inc shows a quality rating of 5.5 and intrinsic value of $67.5 for its $11.1B market cap HCM player. Metrics feature $1,893.3M revenue, $192.0M free cash flow (10.1% margin), 11.7% growth, 52.9% gross margin, ROIC 2.6%, and 22.1% debt, with mild -1.8% 1Y return.
Growth in HCM workforce management supports its profile.
Key Catalysts
- Solid revenue growth 11.7%
- Improving FCF $192.0M
- Reasonable debt 22.1%
- Stable 1Y performance -1.8%
Risk Factors
- Low ROIC 2.6%
- Moderate FCF margin 10.1%
- Integration risks post-merger
Stock #6: Paycom Software, Inc. (PAYC)
| Metric | Value |
|---|---|
| Market Cap | $7,524.1M |
| Quality Rating | 7.0 |
| Intrinsic Value | $209.1 |
| 1Y Return | -34.2% |
| Revenue | $2,001.2M |
| Free Cash Flow | $392.5M |
| Revenue Growth | 9.7% |
| FCF margin | 19.6% |
| Gross margin | 81.8% |
| ROIC | 48.0% |
| Total Debt to Equity | 4.9% |
Investment Thesis
Paycom Software, Inc. earns a 7.0 quality rating and $209.1 intrinsic value at $7,524.1M market cap. It reports $2,001.2M revenue, $392.5M FCF (19.6% margin), 9.7% growth, 81.8% gross margin, standout ROIC 48.0%, and 4.9% debt, despite -34.2% 1Y return.
Elite margins position it strongly in HCM.
Key Catalysts
- Exceptional ROIC 48.0%
- High gross margin 81.8%
- Strong FCF growth potential
- Low debt 4.9%
Risk Factors
- 1Y decline -34.2%
- Payroll competition
- Growth moderation 9.7%
Stock #7: Paylocity Holding Corporation (PCTY)
| Metric | Value |
|---|---|
| Market Cap | $7,332.3M |
| Quality Rating | 6.7 |
| Intrinsic Value | $139.5 |
| 1Y Return | -33.0% |
| Revenue | $1,640.4M |
| Free Cash Flow | $381.8M |
| Revenue Growth | 13.3% |
| FCF margin | 23.3% |
| Gross margin | 68.8% |
| ROIC | 36.3% |
| Total Debt to Equity | 11.6% |
Investment Thesis
Paylocity Holding Corporation has a 6.7 quality rating and $139.5 intrinsic value for $7,332.3M market cap. Data shows $1,640.4M revenue, $381.8M FCF (23.3% margin), 13.3% growth, 68.8% gross margin, ROIC 36.3%, and 11.6% debt, with -33.0% 1Y return.
High growth and ROIC appeal for HCM analysis.
Key Catalysts
- Robust revenue growth 13.3%
- High ROIC 36.3%
- Solid FCF margin 23.3%
- Manageable debt 11.6%
Risk Factors
- Sharp 1Y drop -33.0%
- SaaS valuation pressures
- Customer concentration
Stock #8: Asure Software, Inc. (ASUR)
| Metric | Value |
|---|---|
| Market Cap | $260.4M |
| Quality Rating | 5.0 |
| Intrinsic Value | $29.3 |
| 1Y Return | -19.1% |
| Revenue | $132.0M |
| Free Cash Flow | $16.7M |
| Revenue Growth | 14.5% |
| FCF margin | 12.6% |
| Gross margin | 67.1% |
| ROIC | (6.4%) |
| Total Debt to Equity | 20.8% |
Investment Thesis
Asure Software, Inc. features a 5.0 quality rating and $29.3 intrinsic value at $260.4M market cap. It has $132.0M revenue, $16.7M FCF (12.6% margin), 14.5% growth, 67.1% gross margin, negative ROIC -6.4%, and 20.8% debt, with -19.1% 1Y return.
Growth offsets efficiency challenges in small-cap HCM.
Key Catalysts
- Strong revenue growth 14.5%
- Positive FCF $16.7M
- Attractive gross margin 67.1%
Risk Factors
- Negative ROIC -6.4%
- Small cap volatility
- Debt levels 20.8%
Stock #9: DHI Group, Inc. (DHX)
| Metric | Value |
|---|---|
| Market Cap | $78.4M |
| Quality Rating | 5.1 |
| Intrinsic Value | $2.0 |
| 1Y Return | -41.2% |
| Revenue | $131.2M |
| Free Cash Flow | $9,682.0K |
| Revenue Growth | (9.1%) |
| FCF margin | 7.4% |
| Gross margin | 81.8% |
| ROIC | (3.9%) |
| Total Debt to Equity | 40.6% |
Investment Thesis
DHI Group, Inc. scores 5.1 quality rating and $2.0 intrinsic value for $78.4M market cap. Metrics include $131.2M revenue, $9,682.0K FCF (7.4% margin), -9.1% growth, 81.8% gross margin, negative ROIC -3.9%, and 40.6% debt, with -41.2% 1Y return.
Niche HCM job board with turnaround potential.
Key Catalysts
- High gross margin 81.8%
- Positive FCF generation
Risk Factors
- Revenue decline -9.1%
- Negative ROIC -3.9%
- High debt 40.6% and 1Y loss -41.2%
Stock #10: Atossa Therapeutics, Inc. (ATOS)
| Metric | Value |
|---|---|
| Market Cap | $70.6M |
| Quality Rating | 5.9 |
| Intrinsic Value | $1.5 |
| 1Y Return | -34.7% |
| Revenue | $0.0 |
| Free Cash Flow | ($26.3M) |
| Revenue Growth | (100.0%) |
| FCF margin | N/A |
| Gross margin | N/A |
| ROIC | 851.2% |
| Total Debt to Equity | 0.0% |
Investment Thesis
Atossa Therapeutics, Inc. has a 5.9 quality rating and $1.5 intrinsic value at $70.6M market cap. No revenue, negative FCF (-$26.3M, N/A margin), -100.0% growth, N/A gross margin, extreme ROIC 851.2%, and 0% debt, with -34.7% 1Y return.
Early-stage healthcare play with high ROIC volatility.
Key Catalysts
- No debt 0%
- Elevated ROIC 851.2% from low base
Risk Factors
- Zero revenue and negative FCF
- Revenue contraction -100.0%
- Biotech development risks
Portfolio Diversification Insights
These 10 HCM-focused stocks span large-cap stability (SAP, WDAY at $236.7B-$46.5B) to micro-caps (DHX, ATOS under $100M), primarily in technology/software 90% with HUM adding healthcare exposure. Core holdings like PAYX and PAYC offer high ROIC (19.6%-48.0%) and low debt for defense, while growth names like PCTY (13.3% revenue growth) and ASUR 14.5% provide upside. Allocation: 70% mid/large-cap for stability, 20% small-cap growth, 10% speculative (ATOS). Together, they balance high gross margins (avg. ~70%) with FCF positivity (most), reducing sector-specific risks like hiring slowdowns via cross-HCM sub-themes (payroll, workforce mgmt).
Market Timing & Entry Strategies
Consider positions during HCM sector dips, as negative 1Y returns (-1.8% to -41.2%) align with undervaluation (intrinsic values often 2-10x current implied prices). Monitor Q1 2026 earnings for revenue growth rebounds (e.g., PAYX's 12.4%). Dollar-cost average into high-quality names (WDAY 10.0 rating) on weakness below intrinsic thresholds. Pair with ValueSense screeners for ROIC >15% and FCF margins >20%. Track macro hiring data; enter on stabilization.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- Nelson Peltz - Trian Fund Management Portfolio Q3'2025: Top Holdings & Recent Changes
- Principles for Dealing with the Changing World Order by Ray Dalio
- The Ascent of Money by Niall Ferguson
- Principles for Navigating Big Debt Crises by Ray Dalio
- Influence: The Psychology of Persuasion by Robert B. Cialdini Ph.D.
FAQ Section
How were these stocks selected?
These HCM stocks were chosen from ValueSense curated watchlists using intrinsic value, quality ratings (5.0-10.0), ROIC, FCF margins, and revenue growth, focusing on undervalued profiles in human capital management software.
What's the best stock from this list?
Workday (WDAY) leads with a perfect 10.0 quality rating, 28.0% FCF margin, and $217.7 intrinsic value, though analysis should compare personal risk tolerance across all.
Should I buy all these stocks or diversify?
Diversification across market caps (e.g., SAP for scale, PAYC for ROIC) mitigates HCM sector risks; allocate based on portfolio needs rather than concentrating.
What are the biggest risks with these picks?
Key concerns include negative 1Y returns (up to -41.2%), revenue declines in some (DHX -9.1%), low FCF margins (HUM 1.2%), and high debt (HUM 67.8%), plus economic sensitivity.
When is the best time to invest in these stocks?
Optimal entry aligns with market pullbacks widening intrinsic value gaps, post-earnings confirmation of growth (e.g., >10%), and improving macro hiring trends for HCM demand.